Arsanis, Inc. IPO Research Information

Arsanis, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Arsanis, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Arsanis, Inc.	ASNS - NASDAQ	$15.00-$17.00	$10.00	$13.00	4 million	11/16/2017
Underwriter(s): Citigroup, Cowen, Piper Jaffray
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2017-10-20 Terms Added 2017-11-06 Amended Terms 2017-11-15

Arsanis, Inc. Quote & Chart - Click for current quote - ASNS

About Arsanis, Inc. (adapted from Arsanis, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ASNS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.